Malignant Melanoma Archive - IOZK

Long-term follow up of patients with mesothelioma treated with dendritic cell therapy in three phase I trials.

2021-08-09/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-08-09 / J Clin Oncol 39, 2021 (suppl 15; abstr 2618)

Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

2021-08-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-08-01 / Melanoma Res 2021 08;31(4):378-388

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy

2021-07-19/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2021-07-19 / Sci Rep 2021 Jul;11(1):14661

A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma

2021-06-29/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-06-29 / J Eur Acad Dermatol Venereol 2021 Oct;35(10):1976-1986

Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials

2021-05-19/in Dendritic Cells, International Publications, Malignant Melanoma, Malignant Pleural Mesothelioma /von 2021-05-19 / Vaccines (Basel) 2021 May;9(5)

Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis

2021-05-12/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-05-12 / Cancer Med 2021 Jul;10(13):4302-4311

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

2021-02-27/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-27 / Ann Surg Oncol 2021 Oct;28(11):6126-6137

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination

2021-02-26/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-02-26 / Ann Surg Oncol 2021 10;28(11):6138-6139

Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

2020-04-21/in Dendritic Cells, International Publications, Malignant Melanoma /von 2020-04-21 / J Transl Med 2020 04;18(1):176

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma

2020-02-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2020-02-01 / J Immunother Cancer 2020 02;8(1)